Skip to main content
$2.88 -$0.06 (-2.0%)

04:00 PM EDT on 10/03/23

ESSA Pharma Inc. (NASDAQ:EPIX)

CAPS Rating: No stars

Biopharmaceutical company focused on discovering, developing and commercializing pharmaceutical products to diagnose, treat and manage patients. Its four therapeutic product candidates treat depression, Alzheimer's, cardiovascular diseases and obesity.

Current Price $2.88 Mkt Cap $129.7M
Open $2.94 P/E Ratio -4.63
Prev. Close $2.88 Div. (Yield) $0.00 (0.0%)
Daily Range $2.65 - $2.94 Volume 49,978
52-Wk Range $1.40 - $5.16 Avg. Daily Vol. 31,463

Caps

How do you think NASDAQ:EPIX will perform against the market?

Add Stock to CAPS Watchlist

All Players

36 Outperform
6 Underperform
 

All-Star Players

4 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EPIX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mchuley (< 20)
Submitted January 18, 2008

Alzheimer's drug is promising, as well as, depression drug. They are a long ways from coming to market but within the next few months i see the stock at minimum 30% higher

Sensiblemoney (43.58)
Submitted September 19, 2007

Recovery from recent mergers not yet complete. Has attracted the interest of some "big fish" though.

Fools bullish on NASDAQ:EPIX are also bullish on:

Fools bearish on NASDAQ:EPIX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EPIX.

Recs

0
Member Avatar moneytalk500 (< 20) Submitted: 3/24/2008 3:26:09 PM : Outperform Start Price: $1.51 NASDAQ:EPIX Score: -133.06

alzheimer is going to affect trhee time the people according to a studid and this company have one of the best drug to combact alzheimer this company is going up up and up

Recs

1
Member Avatar mchuley (< 20) Submitted: 1/18/2008 5:05:59 PM : Outperform Start Price: $2.77 NASDAQ:EPIX Score: -241.42

Alzheimer's drug is promising, as well as, depression drug. They are a long ways from coming to market but within the next few months i see the stock at minimum 30% higher

Recs

0
Member Avatar REM71682 (< 20) Submitted: 1/15/2008 10:37:32 PM : Outperform Start Price: $3.49 NASDAQ:EPIX Score: -237.34

Pharmaceutical company with a drug currently in test trials which will drastically improve cognitive performance related to alzheimers disease. If drug is approved, stock goes through the roof.

Leaderboard

Find the members with the highest scoring picks in EPIX.

Score Leader

TMFNosediveflip

TMFNosediveflip (38.00) Score: +272.70

The Score Leader is the player with the highest score across all their picks in EPIX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TMFNosediveflip 38.00 9/25/2006 Underperform 1Y $4.30 -33.02% +239.68% +272.70 0 Comment
Bkube < 20 10/17/2006 Underperform 3M $4.35 -33.79% +230.62% +264.42 0 Comment
halldd 45.80 8/28/2007 Underperform NS $4.30 -33.02% +203.63% +236.66 0 Comment
zxchux < 20 3/6/2008 Underperform NS $2.72 +5.88% +234.44% +228.56 0 Comment
Sensiblemoney 43.58 9/20/2007 Underperform 1Y $4.22 -31.75% +189.42% +221.17 1 Comment
4T9RJoe 52.10 3/24/2008 Underperform 5Y $1.51 +90.73% +222.73% +132.00 0 Comment
moneytalk500 < 20 3/24/2008 Outperform 3W $1.51 +90.73% +223.78% -133.06 1 Comment
BigJello < 20 12/27/2007 Outperform 1Y $3.95 -27.09% +195.10% -222.19 0 Comment
MotorolaMaster 37.27 2/19/2008 Outperform NS $3.19 -9.72% +221.43% -231.14 0 Comment
Novardis < 20 8/22/2007 Outperform 3Y $4.10 -29.76% +203.60% -233.36 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EPIX.